ERBB2 and cancer: As an orthogonal method of inducing T cell exhaustion, we acutely or chronically stimulated HER2-targeted CAR T cells with or without BATF3 OE with HER2+ cancer cells (Fig. 4, Supplementary Fig. 8 and Supplementary Note 8).